Benzinga's Top Initiations

Analysts at UBS initiated coverage on shares of Ecolab (NYSE: ECL ) with a “buy” rating. The target price for Ecolab is set to $120. Ecolab's stock closed at $107.48 yesterday. Analysts at FBR Capital initiated coverage on shares of Valeant Pharmaceuticals International (NYSE: VRX ) with an “outperform”